Related Experiment Video

Updated: Aug 15, 2026

Patch Clamp and Perfusion Techniques for Studying Ion Channels Expressed in Xenopus oocytes
10:19

Patch Clamp and Perfusion Techniques for Studying Ion Channels Expressed in Xenopus oocytes

Published on: January 10, 2011

[Pharmacological basis of Ca2+ channels and Ca2+ channel antagonists]

Satomi Adachi-Akahane1

  • 1Department of Pharmacology, Faculty of Medicine, School of Medicine, Toho University.

Clinical Calcium
|October 4, 2005
PubMed

Insights

Calcium (Ca2+) is vital for cell functions. Calcium channel blockers selectively target these channels, offering tissue-specific effects and improved side effect profiles in newer generations.

Area of Science:

  • Biochemistry and Molecular Biology
  • Pharmacology
  • Cell Physiology

Context:

  • Calcium ions (Ca2+) are crucial intracellular messengers involved in diverse cellular processes, including muscle excitation-contraction coupling, neurotransmitter secretion, and neural transmission.
  • Voltage-dependent L-type calcium channels (LTCCs) are transmembrane proteins that regulate Ca2+ influx into cells upon membrane depolarization.
  • Calcium channel blockers (CCBs), also known as calcium antagonists, are a class of drugs that selectively inhibit LTCCs, impacting cellular functions dependent on calcium signaling.

Purpose:

  • To discuss the multifaceted roles of calcium ions in cellular physiology.
  • To explain the mechanism of action of voltage-dependent L-type calcium channels.
  • To review the pharmacological properties and molecular basis of calcium channel blockers, including newer, long-acting formulations.

Summary:

  • Calcium ions (Ca2+) are essential regulators of numerous cellular functions, including muscle contraction, secretion, and neural signaling.
  • Voltage-dependent L-type calcium channels mediate calcium influx, and their blockade by calcium channel blockers (CCBs) forms the basis of their therapeutic effects.
  • CCBs exhibit tissue-specific actions due to variations in channel expression and function, leading to distinct pharmacological profiles. Advanced CCBs are designed to mitigate side effects associated with older agents.

Impact:

  • Understanding the roles of Ca2+ and the mechanisms of CCBs is fundamental for developing targeted therapies for cardiovascular and neurological conditions.
  • The tissue-specific pharmacology of CCBs allows for tailored treatment strategies, minimizing adverse effects and optimizing therapeutic outcomes.
  • Research into the molecular basis of CCB action continues to drive the development of more effective and safer drugs for managing various diseases.

More Related Videos

Single-Cell Calcium Imaging for Studying the Activation of Calcium Ion Channels07:17

Single-Cell Calcium Imaging for Studying the Activation of Calcium Ion Channels

Published on: December 13, 2024

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators07:41

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators

Published on: February 20, 2018

Related Concept Videos

Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Antiepileptic Drugs: Calcium Channel Blockers01:17

Antiepileptic Drugs: Calcium Channel Blockers

Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...